ETFIQData as of Nov 18, 2026. · etfiq.com/funds/medx

MEDX Fact Sheet: Horizon Kinetics Medical ETF

Share
$36.64
close, Nov 18, 2026

Over the year to Nov 18, 2026, MEDX returned +12.4% in total and charged 0.85% a year.

1-year total return
+12.4%
to Nov 18, 2026
Expense ratio
0.85%
a year
Net flow, 12 months to Jun 30, 2026
−$1.8m
monthly N-PORT basis to Jun 30, 2026

Growth of $10,000, 1 year

MEDX $11,236 +12.4% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+2.0%
3 months−3.2%
Year to date+10.3%
1 year+12.4%
3 years+39.7%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Eli Lilly & Co18.46%
AbbVie Inc8.85%
Novartis AG6.89%
Johnson & Johnson5.59%
Alkermes PLC5.53%
AstraZeneca PLC4.99%
Ionis Pharmaceuticals Inc4.53%
Bristol-Myers Squibb Co4.42%
Merck & Co Inc3.96%
Amgen Inc3.91%

MEDX top ten by weight, 67.1% of the fund, of its 31 equity positions, from the holdings filed for Jun 30, 2026.

Facts

Equity fund · Actively managed · First traded Jan 31, 2023 · Benchmark Its own holdings, as of Jun 30, 2026; its prospectus names no index it tracks

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, MEDX Fact Sheet: Horizon Kinetics Medical ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/medx/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/medx.